PCN256 - Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States

التفاصيل البيبلوغرافية
العنوان:	PCN256 - Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States
المؤلفون:	Mhatre, S, Lin, S, Surinach, A, Vohra, R, Satram-Hoang, S, Simpson, J, Wallen, H, Ogale, S, Gong, J, Pal, SK, George, DJ
المصدر:	In Value in Health November 2016 19(7):A755-A755
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	10983015
DOI:	10.1016/j.jval.2016.09.2332